Orchestrators / Life Sciences / Med Tech / AI Post Market Monitor
Post-market surveillance — AE and complaint intake, clinical and HEOR evidence generation, and registry follow-up.
24/7 complaint and adverse event intake with structured, report-ready capture; registry follow-up calls at protocol intervals; clinical and HEOR evidence generation, PROs, utilization, outcomes, collected conversationally; payer-facing HEOR data programs; recall and field-safety outreach with documented dispositions; safety information delivery; full audit trail.
Regulatory obligation at scale: Post-market surveillance and post-market clinical follow-up requirements (and US 522-style studies) are met without site or call-center surge burden.
Registry completeness: The evidence payers and regulators increasingly demand gets collected at rates manual programs can’t sustain – conversational instruments measure ~66% completion (Jul 2026).
Recall execution: Every affected patient contacted and documented in days.
For devices, approval is no longer the finish line – regulators want surveillance and follow-up evidence for the life of the product, payers want outcomes before they pay, and a registry that goes quiet is a liability. The work is thousands of small, structured conversations a year that no manufacturer wants to staff. This product is the standing capacity: it answers the complaint line at 2am and files a case-ready record, calls the registry cohort on schedule until the dataset is complete, collects the quality-of-life scores HEOR needs, and, when a field action comes, reaches every affected patient with a documented outcome. Staying on market becomes an operating capability instead of a scramble.
